Page last updated: 2024-09-04

beta-lactams and ro13-9904

beta-lactams has been researched along with ro13-9904 in 87 studies

Compound Research Comparison

Studies (beta-lactams)	Trials (beta-lactams)	Recent Studies (post-2010) (beta-lactams)	Studies (ro13-9904)	Trials (ro13-9904)	Recent Studies (post-2010) (ro13-9904)
7,579	179	3,395	6,815	798	2,755

Research

Studies (87)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (3.45)	18.7374
1990's	4 (4.60)	18.2507
2000's	39 (44.83)	29.6817
2010's	32 (36.78)	24.3611
2020's	9 (10.34)	2.80

Authors

Authors	Studies
Bellido, F; Charnas, R; Lucain, C; Marchou, B; Pechère, JC	1
Slack, MP	1
Neu, HC	1
Angehrn, P; Hubschwerlen, C; Kania, M; Page, MG; Richter, HG; Specklin, JL; Winkler, FK	1
Coudron, PE; Moland, ES; Sanders, CC	1
Verbist, L; Verhaegen, J	1
Angehrn, P; Gubernator, K; Hubschwerlen, C; Page, MG; Specklin, JL	1
Chen, M; Xu, Y; Zhang, S	1
Caballero-Lopez, J; Carides, A; Friedland, IR; Ortiz-Ruiz, G; Woods, GL	1
Friedland, I; Jiang, Q; Legua, P; Lema, J; Moll, J; Woods, G	1
Cajigas, J; Gesser, RM; Imbeault, D; Jasovich, A; Jiang, Q; Jimenez-Cruz, F; Woods, GL	1
Burdmann, EA; Gesser, RM; Jiang, Q; Reyna, OG; Tomera, KM; Wimmer, WM; Woods, GL	1
Adeyi, B; Fernandez, A; Geib, J; Hassett, JM; Teppler, H; Woods, GL; Yellin, AE	1
Friedland, I; Majumdar, A; Mixson, LA; Motyl, M; Woods, GL	1
Cambronero-Hernandez, E; Carides, A; Isaacs, R; Oliveria, T; Rohlf, J; Simon, S; Vetter, N	1
Gesser, RM; McCarroll, K; Teppler, H; Woods, GL	1
Gunderson, B; Hermsen, ED; Hovde, LB; Ibrahim, KH; Rotschafer, JC; Rotschafer, SE	1
Acosta, F; Cottagnoud, M; Cottagnoud, P; Pfister, M; Täuber, MG	1
Friedland, IR; Isaacs, RD; McCarroll, KA; Woods, GL	1
Carides, A; Friedland, I; Isaacs, R; Ortiz-Ruiz, G; Vetter, N; Woods, GL	1
Gesser, RM; Jiang, Q; Wells, WG; Woods, GL	1
Friedland, IR; Gesser, RM; Herman, G; Isaacs, R; Meibohm, A; Mistry, G; Teppler, H; Woods, GL	1
DiNubile, MJ; Friedland, IR; McCarroll, KA; Woods, GL	1
Datta, P; Gupta, V; Mishra, B; Thakur, A	1
Bulitta, J; Burkhardt, O; De Roux, A; Kruse, G; Kurowski, M; Lode, H; Nord, CE; Pletz, MW; Rau, M	1
Azanza, JR; Campanero, MA; García-Quetglas, E; Sádaba, B	1
Bergles, DE; Bruijn, LI; Chung, DS; Dykes Hoberg, M; Fisher, PB; Gupta, P; Haenggeli, C; Huang, YH; Jin, L; Patel, S; Regan, MR; Rothstein, JD; Su, ZZ; Toan, SV; Vidensky, S	1
Cleveland, DW; Miller, TM	1
Bourdon, S; Dabernat, H; Lemarié, C; Perez, L	1
Eisenstein, M	1
Secko, D	1
Hosaka, Y; Inoue, M; Kaieda, S; Okamoto, R; Okitsu, N; Takahashi, H; Yano, H	1
Chan, CY; Dinubile, MJ; Friedland, I; Giezek, H; Motyl, MR; Quinn, JP; Shivaprakash, M; Weinstein, RA	1
Caballero-Granado, FJ; Docobo-Pérez, F; García-Curiel, A; Jiménez-Mejías, ME; Moreno-Maqueda, I; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C	1
Beghi, E; Bendotti, C; Mennini, T	1
Donskey, CJ; Pultz, NJ; Stiefel, U	1
Borbone, S; Cascone, C; Mezzatesta, ML; Santagati, M; Stefani, S	1
Alves Filho, JC; Cunha, FQ; D'Avila, LC; da Cunha, AA; de Oliveira, JR; Dias, FS; Leite, CE; Lunardelli, A; Machado, DP; Nunes, FB; Poli de Figueiredo, CE; Poloni, JA; Ruschel, RE; Saciura, VC; Simões Pires, MG	1
Li, JT; Markus, P; Matesic, D; Park, M	1
Amin, M; Rawls, SM; Robinson, W; Tallarida, R	1
Bittner, S; Fahlke, C; Kotsiari, A; Melzer, N; Meuth, SG; Stangel, M; Torres-Salazar, D; Weidenfeller, C; Wiendl, H; Zozulya, AL	1
Brunner, M; Burkhardt, O; Derendorf, H; Lobmeyer, MT; Röck, K; Sahre, M; Schmidt, S	1
Arguedas, A; Blumer, J; Botet, FA; Cespedes, J; Gesser, R; Snyder, T; Wang, J; West, J; Wimmer, W; Yogev, R	1
Ahsman, MJ; Mathot, RA; Tibboel, D; Wildschut, ED	1
Chang, KT; Ledesma, KR; Quinn, JP; Tam, VH; Wang, TY	1
García, E; García, FJ; García, JE; García, MB; García, MI; González, B; Lozano, FS	1
Gómez del Valle, C; Matía, M; Pérez-Calvo, JI; Torralba, MÁ	1
Bellón, T; Bobolea, ID; Cabañas, R; Fiandor-Román, AM; Jurado-Palomo, J; López-Serrano, MC; Prior, N; Quirce, S	1
Gunduz, O; Oltulu, C; Ulugol, A	1
Corley, G; Henry, C; Kim, JK; Rasmussen, BA; Rawls, SM; Walker, EA; Ward, SJ	1
Chen, Z; He, Y; Wang, ZJ	1
Chau, F; Fantin, B; Le, P; Lefort, A; Lepeule, R; Massias, L; Nucci, A; Ruppé, E	1
Davies, TA; Flamm, RK; Lynch, AS	1
Golparian, D; Lahra, MM; Limnios, A; Ohnishi, M; Tapsall, JW; Unemo, M; Whiley, D	1
Chung, MH; Kim, HY; Kim, JY; Kim, MJ; Lee, JS; Lee, MS; Park, DW; Park, YS; Peck, KR; Yeom, JS	1
Pan, X; Pei, Z; Qiu, W; Shi, Z; Wang, W; Wei, J; Xiao, G	1
Aguilar, L; Alou, L; Cafini, F; García, E; Giménez, MJ; Navarro, A; Ramos-Sevillano, E; Rodríguez-Sosa, C; Sevillano, D; Yuste, J	1
Corley, G; Kovalevich, J; Langford, D; Rawls, SM; Yen, W	1
Chiu, CH; Hsieh, YC; Hsu, MH; Su, LH	1
Cai, C; Gu, Y; Huang, K; Lu, J; Tang, Y; Xue, J	1
Bai, N; Cai, Y; Liang, B; Liu, Y; Sun, C; Wang, J; Wang, R; Zhang, L	1
Kees, F; Kees, MG; Kratzer, A; Liebchen, U; Schleibinger, M	1
Bes, M; Clair, P; Dauwalder, O; Dumitrescu, O; Freydière, AM; Laurent, F; Martra, A; Reix, P; Renzoni, A; Reverdy, ME; Roch, M; Vandenesch, F	1
Calvo, G; Llauradó-Serra, M; Martín-Loeches, I; Pontes, C; Soy, D; Ulldemolins, M; Vaquer, S	1
Caldwell, N; Cao, YK; Dai, WM; Leng, XS; Paschke, A; Qiu, HZ; Shen, JF; Wang, J; Zhao, YJ; Zhu, WH	1
Chang, FY; Chiu, CH; Lin, DY; Lin, HA; Lin, HC; Lin, JC; Wang, JX; Yang, YS; Yeh, KM	1
Bettoli, V; Join-Lambert, O; Nassif, A	1
Child, J; Crombleholme, T; Hurst, AL; Olson, D; Parker, SK; Pyle, L; Ranade, D; Somme, S; Stamatoiu, A	1
Basuino, L; Chambers, HF; Choo, EJ; Hamilton, SM; Moise, P	1
Di Maggio, T; Docquier, JD; Landini, G; Pallecchi, L; Rossolini, GM; Sergio, F	1
Akilandeswari, K; Ruckmani, K	1
Ishii, M; Matsumoto, Y; Moriya, K; Okazaki, M; Sato, T; Sekimizu, K; Tabuchi, F; Tatsuno, K	1
Caputo, I; De Rosa, M; Giordano, D; Marabotti, A; Soriente, A; Verdino, A; Vigliotta, G	1
Cassisa, V; Chenouard, R; Eveillard, M; Kempf, M; Lemarié, C; Pailhoriès, H	1
Dittmer, M; Liu, V; Mutgi, KAJ; Swick, BL	1
Hackel, MA; Iaconis, JP; Karlowsky, JA; Sahm, DF	1
Hao, W; He, Y; Mafiz, A; Perera, LN; Sun, S; Xiao, S; Zhang, W; Zhang, Y; Zhou, K	1
Ally, M; Briscoe, S; Lipman, J; McWhinney, B; Roberts, JA; Ungerer, J; Wong, G	1
Maquieira, Á; Morais, S; Peña-Mendizabal, E	1
Gibble, A; Huang, A; Sapozhnikov, J; Zeeck, K	1
Fathi, F; Kohestani, H; Kouhestani, M; Monirinasab, H; Zakariazadeh, M	1
Montealegre, MC; Murray, BE; Singh, KV	1
Guo, X; He, Y; Wang, ZJ	1
Chen, L; He, XP; Hong, SJ; Hua, J; Jing, RC; Luo, XY; Xue, HW; Yuan, CY; Yue, Y	1
Arthur, M; Cusumano, JA; Daffinee, KE; Desbonnet, C; García-Solache, M; LaPlante, KL; Peti, W; Rice, LB; Ugalde-Silva, P	1
Daneman, N; Lam, PW; Leis, JA	1
Bonten, MJM; Buis, DTP; Herpers, BL; Jansen, RR; Prins, JM; Rozemeijer, W; Sieswerda, E; Sigaloff, KCE; Soetekouw, R; van der Meer, JTM; van der Vaart, TW; van Twillert, G; van Werkhoven, CH; Veenstra, J	1

Reviews

6 review(s) available for beta-lactams and ro13-9904

Article	Year
Antipseudomonal beta-lactams. The Journal of antimicrobial chemotherapy, 1981, Volume: 8, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Stability; Lactams; Moxalactam; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	1981
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics. Annual review of pharmacology and toxicology, 1982, Volume: 22 Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam	1982
Safety and tolerability of ertapenem. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ceftriaxone; Clinical Trials as Topic; Community-Acquired Infections; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic	2004
Ertapenem versus ceftriaxone for the treatment of complicated infections: a meta-analysis of randomized controlled trials. Chinese medical journal, 2014, Volume: 127, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Ertapenem; Humans; Intraabdominal Infections; Pneumonia; Randomized Controlled Trials as Topic; Urinary Tract Infections	2014
Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy. Critical care (London, England), 2014, Jun-23, Volume: 18, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Critical Illness; Humans; Meropenem; Piperacillin; Renal Replacement Therapy; Shock, Septic; Thienamycins	2014
Antibiotic Treatment of Hidradenitis Suppurativa. Dermatologic clinics, 2016, Volume: 34, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Clindamycin; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Imipenem; Maintenance Chemotherapy; Metronidazole; Moxifloxacin; Remission Induction; Rifampin	2016

Trials

15 trial(s) available for beta-lactams and ro13-9904

Article	Year
A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Apr-15, Volume: 34, Issue:8 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Tolerance; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome	2002
Safety and local tolerability of intramuscularly administered ertapenem diluted in lidocaine: a prospective, randomized, double-blind study versus intramuscular ceftriaxone. Clinical therapeutics, 2002, Volume: 24, Issue:3 Topics: Aged; Anesthetics, Local; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Double-Blind Method; Ertapenem; Female; Humans; Injections, Intramuscular; Lactams; Lidocaine; Male; Middle Aged; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Infectious	2002
A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults. Urology, 2002, Volume: 60, Issue:1 Topics: Administration, Oral; Adult; Age Factors; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Double-Blind Method; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Infusions, Intravenous; Lactams; Prospective Studies; Treatment Outcome; Urinary Tract Infections	2002
Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:9 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactams; Ceftriaxone; Cephalosporins; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Prospective Studies; Urinary Tract Infections	2002
Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults. International journal of antimicrobial agents, 2002, Volume: 20, Issue:3 Topics: Abdomen; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; beta-Lactams; Ceftriaxone; Double-Blind Method; Drug Therapy, Combination; Ertapenem; Female; Humans; Injections, Intravenous; Lactams; Male; Metronidazole; Middle Aged	2002
A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia. Clinical therapeutics, 2002, Volume: 24, Issue:11 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Double-Blind Method; Ertapenem; Europe; Female; Hospitalization; Humans; Injections, Intramuscular; Injections, Intravenous; Lactams; Latin America; Male; Middle Aged; Pneumonia, Pneumococcal; Prospective Studies; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome; United States	2002
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data. The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:5 Topics: Adult; Aged; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Humans; Lactams; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Urinary Tract Infections	2003
Ertapenem therapy for community-acquired pneumonia in the elderly. Journal of the American Geriatrics Society, 2003, Volume: 51, Issue:11 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Logistic Models; Male; Odds Ratio; Pneumonia, Pneumococcal; Retrospective Studies; Statistics, Nonparametric; Streptococcus pneumoniae; Treatment Outcome	2003
Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Child; Child, Preschool; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome	2004
Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Double-Blind Method; Drug Administration Schedule; Ertapenem; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Lactams; Male; Middle Aged; Multicenter Studies as Topic; Pyelonephritis; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Tract Infections	2004
Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:10 Topics: Adult; beta-Lactams; Ceftriaxone; Cephalosporins; Cross-Over Studies; Double-Blind Method; Ertapenem; Feces; Female; Humans; Intestines; Lactams; Male; Mass Spectrometry; Sex Characteristics	2004
Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carrier State; Ceftriaxone; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intestines; Lactams; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2005
Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection. International journal of antimicrobial agents, 2009, Volume: 33, Issue:2 Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Child; Child, Preschool; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Humans; Infant; Male; Molecular Sequence Data; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections	2009
Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial. Journal of Korean medical science, 2012, Volume: 27, Issue:5 Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Double-Blind Method; Ertapenem; Humans; Odds Ratio; Pyelonephritis; Republic of Korea; Risk Factors; Urinary Tract Infections	2012
Ertapenem prophylaxis of surgical site infections in elective colorectal surgery in China: a multicentre, randomized, double-blind, active-controlled study. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Ceftriaxone; China; Colorectal Surgery; Double-Blind Method; Ertapenem; Female; Humans; Infusions, Intravenous; Laparotomy; Male; Metronidazole; Middle Aged; Placebos; Surgical Wound Infection; Treatment Outcome; Young Adult	2014

Other Studies

66 other study(ies) available for beta-lactams and ro13-9904

Article	Year
Contribution of beta-lactamase hydrolysis and outer membrane permeability to ceftriaxone resistance in Enterobacter cloacae. Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:10 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ceftriaxone; Cell Membrane Permeability; Culture Media; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Hydrolysis; Lactams; Protein Binding	1987
Design, synthesis, and evaluation of 2 beta-alkenyl penam sulfone acids as inhibitors of beta-lactamases. Journal of medicinal chemistry, 1996, Sep-13, Volume: 39, Issue:19 Topics: beta-Lactamase Inhibitors; beta-Lactams; Ceftriaxone; Citrobacter freundii; Clavulanic Acid; Clavulanic Acids; Crystallography, X-Ray; Drug Design; Drug Synergism; Enterobacter; Enzyme Inhibitors; Lactams; Models, Molecular; Molecular Structure; Pseudomonas; Spectrophotometry, Ultraviolet	1996
Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. Journal of clinical microbiology, 1997, Volume: 35, Issue:10 Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefpodoxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Enterobacteriaceae; Hospitals, Veterans; Isoelectric Focusing; Microbial Sensitivity Tests; Species Specificity; Substrate Specificity	1997
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3 Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae	1998
Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazins. Journal of medicinal chemistry, 1998, Oct-08, Volume: 41, Issue:21 Topics: Acetates; beta-Lactamase Inhibitors; beta-Lactams; Ceftriaxone; Cephalosporins; Citrobacter freundii; Drug Design; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Kinetics; Pseudomonas aeruginosa; Sulfonic Acids	1998
[Multicenter evaluation of the antimicrobial activity in vitro for six broad-spectrum beta-lactams in China using the E-test method]. Zhonghua yi xue za zhi, 2000, Volume: 80, Issue:5 Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; China; Imipenem; Microbial Sensitivity Tests; Piperacillin	2000
In vitro activity of ertapenem against common clinical isolates in relation to human pharmacokinetics. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Ertapenem; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes	2002
Mutation prevention concentration of ceftriaxone, meropenem, imipenem, and ertapenem against three strains of Streptococcus pneumoniae. Diagnostic microbiology and infectious disease, 2003, Volume: 45, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Drug Resistance, Microbial; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Microbial Sensitivity Tests; Mutation; Pharmacogenetics; Probability; Sensitivity and Specificity; Streptococcus pneumoniae; Thienamycins	2003
Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:6 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Disease Models, Animal; Ertapenem; Lactams; Meningitis, Pneumococcal; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Vancomycin	2003
Ertapenem as initial antimicrobial monotherapy for patients with chronic obstructive pulmonary disease hospitalized with typical community-acquired pneumonia. Pulmonary pharmacology & therapeutics, 2004, Volume: 17, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Enterobacteriaceae; Ertapenem; Female; Haemophilus influenzae; Hospitalization; Humans; Injections, Intravenous; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Streptococcus pneumoniae; Treatment Outcome	2004
Prevalence of clinical strains resistant to various beta-lactams in a tertiary care hospital in India. Japanese journal of infectious diseases, 2004, Volume: 57, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; India; Microbial Sensitivity Tests; Prevalence	2004
Relationship between pharmacokinetics and pharmacodynamics of beta-lactams and outcome. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefepime; Ceftriaxone; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Treatment Outcome	2004
Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature, 2005, Jan-06, Volume: 433, Issue:7021 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cell Count; Cells, Cultured; Central Nervous System; Drug Evaluation, Preclinical; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Genes, Reporter; In Vitro Techniques; Ischemic Preconditioning; Mice; Mice, Transgenic; Motor Neurons; Neuroprotective Agents; Penicillins; Promoter Regions, Genetic; RNA, Messenger; Transcriptional Activation; United States; United States Food and Drug Administration	2005
Medicine. Treating neurodegenerative diseases with antibiotics. Science (New York, N.Y.), 2005, Jan-21, Volume: 307, Issue:5708 Topics: Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; beta-Lactams; Brain; Ceftriaxone; Clinical Trials as Topic; Drug Evaluation, Preclinical; Excitatory Amino Acid Transporter 2; Glutamic Acid; Humans; Mice; Motor Neurons; Neurodegenerative Diseases; Spinal Cord; Synapses; Synaptic Transmission	2005
[Meningitis due to Haemophilus influenzae with decreased susceptibility to beta-lactams]. Medecine et maladies infectieuses, 2004, Volume: 34, Issue:7 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Drug Resistance, Bacterial; Haemophilus influenzae type b; Humans; Male; Meningitis, Haemophilus	2004
New career possibilities for certain antibiotics? Lab animal, 2005, Volume: 34, Issue:2 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Excitatory Amino Acid Transporter 2; Mice; Nervous System Diseases; Neuroprotective Agents; Spinal Cord	2005
Antibiotics that protect the brain. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2005, Feb-15, Volume: 172, Issue:4 Topics: Amino Acid Transport System X-AG; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glutamic Acid; Mice; Neuroprotective Agents; Promoter Regions, Genetic; RNA, Messenger	2005
In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora. International journal of pediatric otorhinolaryngology, 2005, Volume: 69, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefaclor; Ceftriaxone; Dose-Response Relationship, Drug; Haemophilus paragallinarum; Imipenem; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillins; Time Factors	2005
Efficacy of beta-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillin. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:4 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Ceftriaxone; Endocarditis, Bacterial; Half-Life; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Rabbits; Streptococcus pneumoniae	2005
New ideas for therapy in ALS: critical considerations. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 2006, Volume: 7, Issue:2 Topics: Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Clinical Trials as Topic; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Humans; Mice; Mice, Transgenic	2006
Effect of carbapenem administration on establishment of intestinal colonization by vancomycin-resistant enterococci and Klebsiella pneumoniae in mice. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1 Topics: Animals; beta-Lactams; Carbapenems; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Enterococcus; Ertapenem; Female; Imipenem; Intestines; Klebsiella pneumoniae; Mice; Piperacillin; Sodium Chloride; Time Factors; Vancomycin Resistance	2007
Bactericidal activity of ertapenem against major intra-abdominal pathogens. International journal of antimicrobial agents, 2006, Volume: 28, Issue:5 Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; beta-Lactams; Ceftazidime; Ceftriaxone; Digestive System Diseases; Enterobacter cloacae; Enterococcus faecalis; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus mirabilis; Staphylococcus aureus; Time Factors	2006
Effects of beta-lactam antibiotics and L-arginine in the treatment of experimental sepsis in rats. International journal of antimicrobial agents, 2006, Volume: 28, Issue:5 Topics: Animals; Arginine; Ascitic Fluid; Aztreonam; beta-Lactams; Ceftriaxone; Drug Therapy, Combination; Interleukin-10; Interleukin-1beta; Male; Nitrates; Nitrites; Rats; Rats, Wistar; Sepsis; Survival Analysis; Treatment Outcome; Tumor Necrosis Factor-alpha	2006
Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2006, Volume: 97, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Critical Pathways; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Preoperative Care; Skin Tests; Treatment Outcome; Vancomycin	2006
The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats. British journal of pharmacology, 2007, Volume: 151, Issue:7 Topics: Analgesics, Opioid; Analysis of Variance; Animals; Anti-Bacterial Agents; Aspartic Acid; beta-Lactams; Body Temperature; Ceftriaxone; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fever; Glutamic Acid; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Male; Morphine; Rats; Rats, Sprague-Dawley; Riluzole; Time Factors	2007
A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis. PloS one, 2008, Sep-05, Volume: 3, Issue:9 Topics: Amino Acid Transport System X-AG; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Central Nervous System; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Inflammation; Mice; Mice, Inbred C57BL; Models, Biological; Multiple Sclerosis; Neuroglia; Rats	2008
Effect of protein binding on the pharmacological activity of highly bound antibiotics. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Blood Proteins; Cattle; Ceftriaxone; Drug Discovery; Ertapenem; Escherichia coli; Humans; In Vitro Techniques; Models, Biological; Protein Binding; Serum Albumin; Serum Albumin, Bovine; Streptococcus pneumoniae	2008
Microanalysis of beta-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefotaxime; Ceftriaxone; Chromatography, High Pressure Liquid; Humans; Infant, Newborn; Meropenem; Tandem Mass Spectrometry; Thienamycins; Vancomycin	2009
Killing of Escherichia coli by beta-lactams at different inocula. Diagnostic microbiology and infectious disease, 2009, Volume: 64, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ceftriaxone; Colony Count, Microbial; Ertapenem; Escherichia coli; Humans; Microbial Viability; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors	2009
[Activity of Ertapenem and Ceftriaxone in the eradication of Salmonella in a model of experimental peritonitis in mice]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2009, Volume: 22, Issue:3 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Dose-Response Relationship, Drug; Ertapenem; Male; Mice; Peritonitis; Salmonella enterica; Salmonella Infections	2009
[Treatment of community-acquired pneumonia in adults: ertapenem versus cefditoren?]. Medicina clinica, 2010, Oct-16, Volume: 135, Issue:12 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Ertapenem; Humans; Ofloxacin; Pneumonia, Bacterial	2010
Use of the lymphocyte transformation test in the diagnosis of DRESS syndrome induced by ceftriaxone and piperacillin-tazobactam: two case reports. Journal of investigational allergology & clinical immunology, 2010, Volume: 20, Issue:5 Topics: Adrenal Cortex Hormones; Adult; Anticonvulsants; beta-Lactams; Ceftriaxone; Cell Proliferation; Cells, Cultured; Colitis, Ulcerative; Drug Hypersensitivity; Eosinophilia; Epilepsy; Exanthema; Female; Histamine Antagonists; Humans; Lymphocyte Activation; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2010
Role of GLT-1 transporter activation in prevention of cannabinoid tolerance by the β-lactam antibiotic, ceftriaxone, in mice. Pharmacology, biochemistry, and behavior, 2011, Volume: 99, Issue:1 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cannabinoids; Ceftriaxone; Drug Tolerance; Excitatory Amino Acid Transporter 2; Male; Mice; Mice, Inbred BALB C; Pain Measurement	2011
Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl/6 mice. Behavioural pharmacology, 2011, Volume: 22, Issue:4 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Dose-Response Relationship, Drug; Excitatory Amino Acid Transporter 2; Food; Male; Mice; Mice, Inbred C57BL; Motivation; Reinforcement Schedule; Reinforcement, Psychology; Reward; Self Administration	2011
The beta-lactam antibiotic, ceftriaxone, inhibits the development of opioid-induced hyperalgesia in mice. Neuroscience letters, 2012, Feb-16, Volume: 509, Issue:2 Topics: Analgesics, Opioid; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Down-Regulation; Excitatory Amino Acid Transporter 2; Hyperalgesia; Male; Mice; Mice, Inbred ICR; Morphine; Spinal Cord; Up-Regulation	2012
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Cefoxitin; Ceftriaxone; Conjugation, Genetic; Disease Models, Animal; Drug Administration Schedule; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Kidney; Mice; Microbial Sensitivity Tests; Mutation Rate; Plasmids; Urinary Bladder; Urinary Tract Infections	2012
Activity of ceftobiprole against Streptococcus pneumoniae isolates exhibiting high-level resistance to ceftriaxone. International journal of antimicrobial agents, 2012, Volume: 39, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Ceftriaxone; Cephalosporins; Genotype; Humans; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Penicillins; Peptide Synthases; Sequence Analysis, DNA; Streptococcus pneumoniae	2012
In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea? Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Drug Resistance, Bacterial; Ertapenem; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae	2012
The beta-lactam antibiotic, ceftriaxone, provides neuroprotective potential via anti-excitotoxicity and anti-inflammation response in a rat model of traumatic brain injury. The journal of trauma and acute care surgery, 2012, Volume: 73, Issue:3 Topics: Analysis of Variance; Animals; beta-Lactams; Biopsy, Needle; Blotting, Western; Brain Edema; Brain Injuries; Ceftriaxone; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Excitatory Amino Acid Transporter 2; Immunohistochemistry; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Survival Rate; Treatment Outcome; Up-Regulation	2012
Cefditoren and ceftriaxone enhance complement-mediated immunity in the presence of specific antibodies against antibiotic-resistant pneumococcal strains. PloS one, 2012, Volume: 7, Issue:9 Topics: Acute-Phase Proteins; Animals; Anti-Bacterial Agents; Antibodies; beta-Lactams; Ceftriaxone; Cephalosporins; Complement Activation; Complement C1q; Complement C3c; Drug Resistance, Microbial; Egtazic Acid; Flow Cytometry; Humans; Immune System; Mice; Phagocytosis; Streptococcus pneumoniae	2012
Cocaine-induced loss of white matter proteins in the adult mouse nucleus accumbens is attenuated by administration of a β-lactam antibiotic during cocaine withdrawal. The American journal of pathology, 2012, Volume: 181, Issue:6 Topics: Aging; Animals; beta-Lactams; Caspase 3; Ceftriaxone; Cocaine; Excitatory Amino Acid Transporter 2; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Nucleus Accumbens; Oligodendroglia; Substance Withdrawal Syndrome	2012
Alterations of penicillin-binding proteins in pneumococci with stepwise increase in β-lactam resistance. Pathogens and disease, 2013, Volume: 67, Issue:1 Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftriaxone; DNA Mutational Analysis; DNA, Bacterial; Humans; Penicillin-Binding Proteins; Penicillins; Streptococcus pneumoniae	2013
Analysis on 113 cases of adverse reactions caused by β-lactam antibiotics. African journal of traditional, complementary, and alternative medicines : AJTCAM, 2013, Volume: 10, Issue:4 Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Child; Female; Gastrointestinal Tract; Humans; Male; Middle Aged; Nervous System; Retrospective Studies; Skin; Young Adult	2013
Determination of free vancomycin, ceftriaxone, cefazolin and ertapenem in plasma by ultrafiltration: impact of experimental conditions. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2014, Jun-15, Volume: 961 Topics: beta-Lactams; Cefazolin; Ceftriaxone; Drug Stability; Ertapenem; Humans; Protein Binding; Ultrafiltration; Vancomycin	2014
Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Ceftriaxone; Drug Resistance, Bacterial; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Staphylococcus aureus; Vancomycin; Vancomycin Resistance	2014
Comparison of the effectiveness and antibiotic cost among ceftriaxone, ertapenem, and levofloxacin in treatment of community-acquired complicated urinary tract infections. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Costs and Cost Analysis; Ertapenem; Escherichia coli; Female; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult	2016
Once-Daily Ceftriaxone Plus Metronidazole Versus Ertapenem and/or Cefoxitin for Pediatric Appendicitis. Journal of the Pediatric Infectious Diseases Society, 2017, Mar-01, Volume: 6, Issue:1 Topics: Abdominal Abscess; Adolescent; Appendectomy; Appendicitis; beta-Lactams; Cefoxitin; Ceftriaxone; Child; Child, Preschool; Cost Savings; Cost-Benefit Analysis; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Ertapenem; Female; Humans; Infant; Laparoscopy; Male; Metronidazole; Retrospective Studies; Treatment Outcome; Young Adult	2017
Daptomycin-β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:7 Topics: Animals; beta-Lactams; Ceftriaxone; Cephalosporins; Daptomycin; Endocarditis, Bacterial; Ertapenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits	2016
Effect of High N-Acetylcysteine Concentrations on Antibiotic Activity against a Large Collection of Respiratory Pathogens. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:12 Topics: Acetylcysteine; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Drug Combinations; Drug Interactions; Enterobacter cloacae; Ertapenem; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Thienamycins	2016
Synergistic antibacterial effect of apigenin with β-lactam antibiotics and modulation of bacterial resistance by a possible membrane effect against methicillin resistant Staphylococcus aureus. Cellular and molecular biology (Noisy-le-Grand, France), 2016, Dec-30, Volume: 62, Issue:14 Topics: Ampicillin; Anti-Bacterial Agents; Apigenin; beta-Lactams; Ceftriaxone; Cell Membrane; Cell Membrane Permeability; Cell Wall; Drug Resistance, Bacterial; Drug Synergism; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission	2016
Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus. The Journal of antibiotics, 2017, Volume: 70, Issue:6 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Bombyx; Ceftriaxone; Disease Models, Animal; Drug Synergism; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance	2017
Synthesis and biological evaluation of the progenitor of a new class of cephalosporin analogues, with a particular focus on structure-based computational analysis. PloS one, 2017, Volume: 12, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cell Survival; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Docking Simulation; Penicillin-Binding Proteins; Structure-Activity Relationship	2017
Staphylococcus saprophyticus: Which beta-lactam? International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017, Volume: 65 Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cystitis; Drug Resistance, Multiple, Bacterial; Empirical Research; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyelonephritis; Staphylococcus saprophyticus; Urinary Tract Infections; Young Adult	2017
Localized, ovoid urticarial plaques with fine, nonfollicular pustules. Clinical and experimental dermatology, 2018, Volume: 43, Issue:2 Topics: Acute Generalized Exanthematous Pustulosis; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Drug Eruptions; Female; Humans; Middle Aged	2018
Analysis of Potential β-Lactam Surrogates To Predict Journal of clinical microbiology, 2018, Volume: 56, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cefotaxime; Ceftazidime; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests	2018
Case study on the soil antibiotic resistome in an urban community garden. International journal of antimicrobial agents, 2018, Volume: 52, Issue:2 Topics: Ampicillin; Anti-Bacterial Agents; Antiporters; Bacterial Proteins; beta-Lactams; Cefoxitin; Ceftriaxone; Chloramphenicol; Cities; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Gardens; Gene Expression; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin; Metagenome; Microbial Sensitivity Tests; Penicillins; Quinolones; Soil Microbiology	2018
Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures. The Journal of antimicrobial chemotherapy, 2018, 11-01, Volume: 73, Issue:11 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Critical Illness; Drug Monitoring; Female; Humans; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Prospective Studies; Treatment Outcome	2018
Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam. Scientific reports, 2020, 09-29, Volume: 10, Issue:1 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Immunoglobulin G; Meropenem; Monobactams; Penicillins; Skin Tests	2020
Comparison of outcomes in urinary tract infections caused by AmpC-harboring organisms treated with AmpC stable versus AmpC susceptible agents. Diagnostic microbiology and infectious disease, 2021, Volume: 101, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections	2021
Study of β-lactam-based drug interaction with albumin protein using optical, sensing, and docking methods. Journal of biological physics, 2022, Volume: 48, Issue:2 Topics: beta-Lactams; Binding Sites; Ceftizoxime; Ceftriaxone; Drug Interactions; Molecular Docking Simulation; Protein Binding; Serum Albumin, Bovine; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Thermodynamics	2022
Enterococcus faecium Clade Competition in the Presence of β-Lactam Antibiotics in a Mouse GI Tract Colonization Model. Antimicrobial agents and chemotherapy, 2022, 11-15, Volume: 66, Issue:11 Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Enterococcus faecium; Gastrointestinal Tract; Mice; Monobactams	2022
Therapeutic potential of β-lactam ceftriaxone for chronic pain in sickle cell disease. Haematologica, 2023, 02-01, Volume: 108, Issue:2 Topics: Anemia, Sickle Cell; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Chronic Pain; Humans	2023
Comparison of the relative efficacy of β-lactam/β-lactamase inhibitors and carbapenems in the treatment of complicated urinary tract infections caused by ceftriaxone-non-susceptible Enterobacterales: a multicentre retrospective observational cohort study. The Journal of antimicrobial chemotherapy, 2023, 03-02, Volume: 78, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Gammaproteobacteria; Humans; Lactams; Retrospective Studies; Urinary Tract Infections	2023
Penicillin-Binding Proteins and Alternative Dual-Beta-Lactam Combinations for Serious Enterococcus faecalis Infections with Elevated Penicillin MICs. Antimicrobial agents and chemotherapy, 2023, 02-16, Volume: 67, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Ceftriaxone; Enterococcus faecalis; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Penicillins	2023
Antibiotic-Induced Neutropenia in Patients Receiving Outpatient Parenteral Antibiotic Therapy: a Retrospective Cohort Study. Antimicrobial agents and chemotherapy, 2023, 03-16, Volume: 67, Issue:3 Topics: Ambulatory Care; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cloxacillin; Humans; Neutropenia; Outpatients; Retrospective Studies; Vancomycin	2023
Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study. The Journal of antimicrobial chemotherapy, 2023, 05-03, Volume: 78, Issue:5 Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Ceftriaxone; Cefuroxime; Floxacillin; Humans; Methicillin; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus	2023